JANEICE HUKILL: Open Payments
NPI 1174945067 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 26 payments from 8 companies in 2025. Trend: 2023 $22 · 2024 $485 · 2025 $1,427
Food & beverage: $1,308Education: $119
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $357 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $242 |
| ABBVIE INC. | 13 | $185 |
| Axsome Therapeutics, Inc. | 2 | $145 |
| Alkermes, Inc. | 3 | $137 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Janssen Pharmaceuticals, Inc | 1 | $118 |
Products named: AUSTEDO XR, CAPLYTA, VRAYLAR, Auvelity, LYBALVI, ABILIFY MAINTENA, COBENFY, SPRAVATO.
Industry payments across MO — which companies pay providers there.
